48,474
edits
(One intermediate revision by the same user not shown) | |||
Line 75: | Line 75: | ||
***[[Hepatocellular carcinoma]].<ref>URL: [http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/Hepatocellular_11protocol.pdf http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/Hepatocellular_11protocol.pdf]. Accessed on: 6 April 2012.</ref> | ***[[Hepatocellular carcinoma]].<ref>URL: [http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/Hepatocellular_11protocol.pdf http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/Hepatocellular_11protocol.pdf]. Accessed on: 6 April 2012.</ref> | ||
*[[Margin status]] usually does not affect the tumour stage. | *[[Margin status]] usually does not affect the tumour stage. | ||
**[[Prostate adenocarcinoma]] - on a practical level bladder neck margin positivity usually up stages, see ''[[bladder neck invasion]]''. | |||
===Nodal stage=== | ===Nodal stage=== | ||
{{Main|Lymph node metastasis}} | |||
*[[lymph node metastasis|Lymph node involvement]]. | *[[lymph node metastasis|Lymph node involvement]]. | ||
*Positive lymph nodes (without mets) often upstage to ''stage III''. | *Positive lymph nodes (without mets) often upstage to ''stage III''. |
edits